News | Bloomberg Business

Secret Rebates Erode Drugmaker Revenue, Industry Study Says

January 18, 2017

Aaron Vandervelde comments on branded drug companies’ share of total US spending on their products and other topics discussed in the paper The Pharmaceutical Supply Chain: Gross Drug Expenditures Realized by Stakeholders, which he coauthored with Eleanor Blalock.

Read the article.


Related Professionals

Eleanor Blalock

Associate Director

Washington, DC

Aaron Vandervelde

Managing Director

Washington, DC